文献速递核素与放射性配体治疗肿瘤 PET/CT

肿瘤控制概率与小尺度蒙特卡罗剂量学:放射性药物治疗中瘤内活性分布异质性的影响

Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy.
PubMed 文献 · J Nucl Med · 2023-07-27

研究基于LNCaP前列腺癌异种移植冷冻切片的数字放射自显影与苏木精-伊红染色,用蒙特卡罗模拟计算225Ac、177Lu和90Y对肿瘤细胞的吸收剂量,并结合肿瘤控制概率(TCP)估算达到高TCP所需的平均注射活度。结果显示,达到90% TCP所需的平均注射活度分别为225Ac 18.3 kBq、177Lu 24.3 MBq、90Y 5.6 MBq。

要点

  • 基于冷冻切片放射自显影与细胞核定位,可避免低细胞密度区域低吸收剂量低估肿瘤反应。
  • 达到90% TCP所需平均注射活度:225Ac 18.3 kBq、177Lu 24.3 MBq、90Y 5.6 MBq。
  • 剂量学模型可估算非均匀瘤内活性摄取下达到足够TCP所需的平均活度。

核心结论

  • 为解释非均匀瘤内活性摄取产生的异质性吸收剂量,剂量学模型可估算达到足够TCP以获治疗反应所需的平均活度。
  • 该方法对于准确评估所建议的放射性药物疗效是必要的。

研究设计与样本

  • 研究评估经[177Lu]Lu-PSMA-617处理的前列腺癌细胞系LNCaP异种移植冷冻切片,采用数字放射自显影并用苏木精和伊红染色。
  • 以数字放射自显影图像定义蒙特卡罗模拟的源,以染色切片检测细胞核位置,将瘤内吸收剂量异质性与细胞密度关联。
  • 模拟针对225Ac、177Lu和90Y进行,计算TCP以估算高TCP所需的平均注射活度,并生成一个活性主要摄取于肿瘤边界的假设病例用于模拟吸收剂量。

主要发现

  • 由染色和模拟结果计算肿瘤细胞每衰变的吸收剂量,以避免低细胞密度肿瘤区域低吸收剂量低估肿瘤反应。
  • 达到90% TCP所需的平均注射活度:225Ac为18.3 kBq(范围18-22 kBq),177Lu为24.3 MBq(范围20-29 MBq),90Y为5.6 MBq(范围5-6 MBq)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In radiopharmaceutical therapy, intratumoral uptake of radioactivity usually leads to heterogeneous absorbed dose distribution. The likelihood of treatment success can be estimated with the tumor control probability (TCP), which requires accurate dosimetry, estimating the absorbed dose rate per unit activity to individual tumor cells. Methods: Xenograft cryosections of the prostate cancer cell line LNCaP treated with [177Lu]Lu-PSMA-617 were evaluated with digital autoradiography and stained with hematoxylin and eosin. The digital autoradiography images were used to define the source in a Monte Carlo simulation of the absorbed dose, and the stained sections were used to detect the position of cell nuclei to relate the intratumoral absorbed dose heterogeneity to the cell density. Simulations were performed for 225Ac, 177Lu, and 90Y. TCP was calculated to estimate the mean necessary injected activity for a high TCP. A hypothetical case of activity mainly taken up on the tumor borders was generated and used to simulate the absorbed dose. Results: The absorbed dose per decay to tumor cells was calculated from the staining and simulation results to avoid underestimating the tumor response from low absorbed doses in tumor regions with low cell density. The mean of necessary injected activity to reach a 90% TCP for 225Ac, 177Lu, and 90Y was found to be 18.3 kBq (range, 18-22 kBq), 24.3 MBq (range, 20-29 MBq), and 5.6 MBq (range, 5-6 MBq), respectively. Conclusion: To account for the heterogeneous absorbed dose generated from nonuniform intratumoral activity uptake, dosimetry models can estimate the mean necessary activity to reach a sufficient TCP for treatment response. This approach is necessary to accurately evaluate the efficacy of suggested radiopharmaceuticals for therapy.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mellhammar E, Dahlbom M, Vilhelmsson-Timmermand O, et al. Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy. J Nucl Med. 2023. PMID: 37934033. doi:10.2967/jnumed.123.265523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。